Dupilumab maintained histologic and endoscopic improvements across all pediatric age groups with EoE, according to Joshua Wechsler, MD.
Joshua Wechsler, MD, MSCI
Advertisement
Joshua Wechsler, MD, MSCI, Medical Director, Eosinophilic Gastrointestinal Diseases Program; Attending Physician, Gastroenterology, Hepatology and Nutrition, Ann & Robert H. Lurie Children’s Hospital of Chicago.
Articles by Joshua Wechsler, MD, MSCI
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
How well do you know the latest genetic testing guidelines?
2
FDA, CDC investigating multistate infant botulism outbreak tied to formula
3
Recurrent nausea and vomiting in an 18-year-old
4
Dupilumab's continued efficacy in pediatric EoE patients, with Joshua Wechsler, MD
5
